Wealthcare Advisory Partners’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,792
Closed -$371K 574
2022
Q1
$371K Sell
9,792
-695
-7% -$25.4K 0.02% 366
2021
Q4
$406K Buy
+10,487
New +$387K 0.02% 365
2021
Q2
Sell
-600
Closed -$20K 710
2021
Q1
$20K Buy
+600
New +$20.6K ﹤0.01% 1194

Other funds holding BOUT

Wealthcare Advisory Partners's BOUT Position: Q2 2022 in Review

Wealthcare Advisory Partners sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2022, closing a stake of 9,792 shares — an estimated $371K sold.

Wealthcare Advisory Partners first reported a position in BOUT in Q1 2021 and held it in 3 quarters. The position peaked at $406K in Q4 2021. 13 funds tracked by Wall St. Rank hold BOUT as of Q2 2022.

  • Wealthcare Advisory Partners reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2022 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 9,792 CapForce IBD Breakout Opportunities ETF shares in Q2 2022, an estimated $371K.
  • Wealthcare Advisory Partners first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2021 and held it in 3 quarters.
  • Wealthcare Advisory Partners's CapForce IBD Breakout Opportunities ETF position peaked at $406K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.